These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38315053)

  • 1. Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs.
    Doyle EH; Aloman C; El-Shamy A; Eng FJ; Kim-Schulze S; Rahman A; Schiano T; Heeger P; Branch AD
    Liver Transpl; 2024 Jul; 30(7):728-741. PubMed ID: 38315053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
    Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
    Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection.
    Cabral MS; Santos TPS; Santos PL; Schinoni MI; Oliveira IS; Pereira AB; Atta AM; Sousa-Atta MLB
    Cytokine; 2018 Feb; 102():200-205. PubMed ID: 28969940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
    Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
    Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
    Dong RQ; Zhou DF; Han R; Zhou JY; Zhao CY; Zhen Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):899-902. PubMed ID: 24636290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.
    Sun B; Abadjian L; Monto A; Freasier H; Pulliam L
    J Infect Dis; 2020 Jul; 222(3):396-406. PubMed ID: 32157304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.
    Dultz G; Gerber L; Zeuzem S; Sarrazin C; Waidmann O
    J Viral Hepat; 2016 Apr; 23(4):267-73. PubMed ID: 26554542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.
    MacParland SA; Pham TN; Guy CS; Michalak TI
    Hepatology; 2009 May; 49(5):1431-41. PubMed ID: 19177592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
    Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
    Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
    Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
    Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection.
    Velazquez VM; Hon H; Ibegbu C; Knechtle SJ; Kirk AD; Grakoui A
    Hepatology; 2012 Dec; 56(6):2071-81. PubMed ID: 22711645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-α-induced CD100 on naïve CD8
    Li BJ; He Y; Zhang Y; Guo YH; Zhou Y; Zhang PX; Wang W; Zhao JR; Li JG; Zuo WZ; Fan C; Jia ZS
    J Int Med Res; 2017 Feb; 45(1):89-100. PubMed ID: 28222623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcript analysis of P2X receptors in PBMCs of chronic HCV patients: an insight into antiviral treatment response and HCV-induced pathogenesis.
    Ashraf W; Manzoor S; Ashraf J; Ahmed QL; Khalid M; Tariq M; Imran M; Aziz H
    Viral Immunol; 2013 Oct; 26(5):343-50. PubMed ID: 24116708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.
    Gardiner D; Lalezari J; Lawitz E; DiMicco M; Ghalib R; Reddy KR; Chang KM; Sulkowski M; Marro SO; Anderson J; He B; Kansra V; McPhee F; Wind-Rotolo M; Grasela D; Selby M; Korman AJ; Lowy I
    PLoS One; 2013; 8(5):e63818. PubMed ID: 23717490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.
    Lund Laursen T; Brøckner Siggard C; Kazankov K; Damgaard Sandahl T; Møller HJ; Ong A; Douglas MW; George J; Tarp B; Hagelskjaer Kristensen L; Lund Laursen A; Hiramatsu A; Nakahara T; Chayama K; Grønbaek H
    Scand J Gastroenterol; 2018 Aug; 53(8):986-993. PubMed ID: 29987961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Immune Imprints of Post-Liver Transplantation Hepatitis C Persist Despite Viral Clearance.
    Aregay A; Engel B; Port K; Vondran FWR; Bremer B; Niehaus C; Khera T; Richter N; Jaeckel E; Cornberg M; Taubert R; Wedemeyer H
    Liver Transpl; 2021 Jun; 27(6):887-899. PubMed ID: 33641215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C.
    Hao C; Zhou Y; He Y; Fan C; Sun L; Wei X; Wang L; Peng M; Wang P; Lian J; Jia Z
    Immunology; 2014 Dec; 143(4):531-8. PubMed ID: 24903732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alteration of CD100 expression on natural killer cells in chronic patients with hepatitis C virus before and after initiation of antiviral treatment].
    He Y; Li B; Zhou Y; Zhang Y; Guo Y; Ji G; Fan C; Jia Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):856-60. PubMed ID: 25108441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.